Core Insights - Lakeside Holding Limited has entered into a Sales Agreement with Sinopharm Holding Hubei New Special Medicine Co., Ltd. for the sale and delivery of critical medicines valued at approximately RMB 11.0 million (around $1.5 million) [1][2] - The agreement is part of a broader partnership with Sinopharm Group, focusing on essential medicine storage, transportation, and logistics services, highlighting Hupan Pharmaceutical's growing role in the Chinese pharmaceutical market [2][3] - The company aims to enhance its market reach and expand its portfolio of pharmaceutical solutions, reinforcing its position as a trusted provider in the industry [3][6] Company Overview - Lakeside Holding Limited is a U.S.-based cross-border supply chain solution provider with a focus on the Asia-Pacific market, operating through subsidiaries like American Bear Logistics and Hupan Pharmaceutical [4][6] - American Bear Logistics provides customized cross-border ocean and airfreight solutions, connecting Asia-based logistics service companies with the U.S. market [5] - The recent acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd. has expanded Lakeside's service scope and enhanced its pharmaceutical logistics and distribution capabilities within China [6]
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary